Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01161771 · ClinicalTrials.gov registry record

Effects of Cataract Extraction Surgery and Limbal Relaxing Incision on Corneal Sensation and Dry Eye

A clinical trial of Dry Eye, sponsored by Allergan.

Completed
Registry status
32
Enrollment target
1
Study location

NCT01161771: Completed study of Dry Eye, sponsored by Allergan.

NCT01161771 is a study of Dry Eye that has completed, run by Allergan. The registered enrollment target is 32 participants, below the 95-participant average among 41 other Dry Eye trials with a reported enrollment target (66% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01161771, a study of Dry Eye, has completed, sponsored by Allergan.

COMPLETED
Registry status
32 participants
Enrollment target
1
Study location

Study Summary

This is a multicenter evaluation of the effects of the cataract extraction and limbal relaxing incisions (LRI) on corneal sensation and dry eye signs and symptoms.

Primary Outcome

The percentage of subjects at month 3 with corneal sensitivity \< 50 mm at any of the locations measured. Corneal sensitivity is evaluated by using a nylon filament to measure the capability of the cornea (clear front portion of the eye) to respond to touch. The longest filament length at which a minimum of the 3 out of 5 stimulus applications produce a positive response from the subject was the corneal touch threshold (sensitivity). Measurements were taken at 5 different locations in each corne

Conditions Studied

Interventions

  • PROCEDURE Cataract Surgery and Limbal relaxing incision

Study Locations (1)

New York

  • - Long Island City

Trial Details

FieldValue
Enrollment Target 32 participants
Start Date 2010-05
Est. Completion 2010-12
Allergan

314 total trials

What the finished NCT01161771 record still lists

NCT01161771 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 32 participants, a relatively small participant target, below the 95-participant average among 41 other Dry Eye trials with a reported enrollment target (66% lower).

The record links to 1 condition, with Dry Eye appearing as the primary indexed condition, and to 1 intervention - of which Cataract Surgery and Limbal relaxing incision is the first listed.

NCT01161771 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT01161771 about?

NCT01161771 is a clinical study titled "Effects of Cataract Extraction Surgery and Limbal Relaxing Incision on Corneal Sensation and Dry Eye". This is a multicenter evaluation of the effects of the cataract extraction and limbal relaxing incisions (LRI) on corneal sensation and dry eye signs and symptoms.

What is the current status of trial NCT01161771?

This trial is currently completed. The enrollment target is 32 participants. The study started on 2010-05. Estimated completion is 2010-12.

What conditions does trial NCT01161771 study?

This clinical trial studies the following conditions: Dry Eye.

What interventions are being tested in trial NCT01161771?

The interventions under investigation include: Cataract Surgery and Limbal relaxing incision (PROCEDURE).

Who is sponsoring clinical trial NCT01161771?

This trial is sponsored by Allergan, which has 314 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01161771 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Dry Eye

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01161771's enrollment target sits among peer trials

32 30th of 41 higher than 12 of 41 other Dry Eye trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Dry Eye trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02445781 · 32 participants · Early Phase 1

    Differing Levels of Hypoglycemia

  • NCT02792270 · 32 participants · NA

    Caloric Restriction In Sarcoma Patients Treated With Pre-Operative RT

  • NCT03068910 · 32 participants · Early Phase 1

    Hyperandrogenemia and Altered Day-night LH Pulse Patterns

  • NCT03208868 · 32 participants · NA

    Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01161771, the US trial registry maintained by the National Library of Medicine. NCT01161771 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.